HomeNKTR • NASDAQ
add
Nektar Therapeutics
Previous close
$26.69
Day range
$26.34 - $28.22
Year range
$6.48 - $37.38
Market cap
518.45M USD
Avg Volume
858.03K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Revenue | 11.18M | -52.42% |
Operating expense | 46.96M | -6.52% |
Net income | -41.59M | 20.57% |
Net profit margin | -372.20 | -66.96% |
Earnings per share | -2.78 | 0.95% |
EBITDA | -35.57M | -1.55% |
Effective tax rate | 0.45% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 175.90M | -35.15% |
Total assets | 207.53M | -39.55% |
Total liabilities | 231.74M | -12.10% |
Total equity | -24.21M | — |
Shares outstanding | 19.02M | — |
Price to book | -13.76 | — |
Return on assets | -38.58% | — |
Return on capital | -50.70% | — |
Cash Flow
Net change in cash
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Net income | -41.59M | 20.57% |
Cash from operations | -45.74M | -21.31% |
Cash from investing | 49.62M | 192.16% |
Cash from financing | 211.00K | 1,010.53% |
Net change in cash | 4.09M | 119.78% |
Free cash flow | -21.16M | -101.14% |
About
Founded
1990
Headquarters
Website
Employees
61